{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T06:21:06Z","timestamp":1791786066221,"version":"4.3.4"},"reference-count":47,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Demographic change is leading to an increasing portion of octogenarians with pancreatic ductal adenocarcinoma (PDAC). Surgery remains a central component of curative-intent treatment. Nevertheless, it carries a risk of potentially life-threatening complications and high morbidity. Whether octogenarians benefit from surgery remains unclear. Methods: Using data from the clinical cancer registries of the 10th National Oncology Quality Conference of the ADT, we divided all patients with PDAC diagnosed between 2015 and 2023 into three age groups (\u226465 years, n = 944; 66\u201379 years, n = 1535; \u226580 years, n = 537) and compared demographics, histopathology, treatment patterns, and survival data. Results: We observed an increasing proportion of octogenarians over the years from 15% in 2015 to 32% in 2023. While they were diagnosed with more favorable tumor stages, they more often received palliative chemotherapy (28% vs. 18%\/19% in the younger cohorts). Only 24% of octogenarians who underwent surgery received adjuvant chemotherapy. Octogenarians had a worse overall and disease-free survival and 90-day mortality than the younger age groups. Furthermore, octogenarians with surgery or chemotherapy with curative intent alone had survival rates comparable to patients with palliative care. Conclusions: Octogenarians largely do not benefit from surgery alone. As only a quarter of octogenarians received adjuvant chemotherapy after surgery, neoadjuvant concepts might be useful for selecting patients who are fit enough to undergo and benefit from multimodal treatment.<\/jats:p>","DOI":"10.3390\/cancers18152423","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:55:41Z","timestamp":1785225341000},"page":"2423","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice?"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5296-6355","authenticated-orcid":false,"given":"Lennart","family":"von Fritsch","sequence":"first","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Abual Naaj","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6622-320X","authenticated-orcid":false,"given":"Jannis","family":"Duhn","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim C.","family":"Honselmann","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Bolm","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Braun","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hryhoriy","family":"Lapshyn","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Litkevych","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Schneider","sequence":"additional","affiliation":[{"name":"Clinical-Epidemiological Cancer Registry Brandenburg-Berlin, 03044 Cottbus, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Reinwald","sequence":"additional","affiliation":[{"name":"Cancer Registry of Rhineland-Palatinate, Institute for Digital Health Data RLP, 55101 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sackmann","sequence":"additional","affiliation":[{"name":"Hessian Cancer Registry, Hessian Office for Health and Care, 60439 Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Klinkhammer-Schalke","sequence":"additional","affiliation":[{"name":"Association of German Tumor Centers (ADT) (Arbeitsgemeinschaft Deutscher Tumorzentren e.V.), 14057 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0743-6128","authenticated-orcid":false,"given":"Sylke Ruth","family":"Zeissig","sequence":"additional","affiliation":[{"name":"Association of German Tumor Centers (ADT) (Arbeitsgemeinschaft Deutscher Tumorzentren e.V.), 14057 Berlin, Germany"},{"name":"Institute of Clinical Epidemiology and Biometry (ICE-B), University of W\u00fcrzburg, 97070 W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Franke","sequence":"additional","affiliation":[{"name":"Association of German Tumor Centers (ADT) (Arbeitsgemeinschaft Deutscher Tumorzentren e.V.), 14057 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hummel","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Medical Center Greifswald, 17475 Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Weitmann","sequence":"additional","affiliation":[{"name":"Central Unit of the Cancer Registry Mecklenburg-Western Pomerania, 17475 Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Fai\u00dft","sequence":"additional","affiliation":[{"name":"Institute for Health Services Research at the Oncology Center Stuttgart e.V., 70176 Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Wittenberg","sequence":"additional","affiliation":[{"name":"Cancer Registry Saxony-Anhalt, 06112 Halle (Saale), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Isabel","family":"Selig","sequence":"additional","affiliation":[{"name":"Cancer Registry Saxony, 01099 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8761-1698","authenticated-orcid":false,"given":"Soo-Zin","family":"Kim-Wanner","sequence":"additional","affiliation":[{"name":"Hessian Cancer Registry, Hessian Office for Health and Care, 60439 Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Central Unit of the Cancer Registry Mecklenburg-Western Pomerania, 17475 Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7651-6183","authenticated-orcid":false,"given":"Tobias","family":"Keck","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8632-166X","authenticated-orcid":false,"given":"Ulrich F.","family":"Wellner","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4985-4723","authenticated-orcid":false,"given":"Steffen","family":"Deichmann","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaer S. A.","family":"Abdalla","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1016\/S1470-2045(16)30403-X","article-title":"Cancer overtakes heart disease as biggest killer in 12 countries","volume":"17","author":"Tanday","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_2","unstructured":"Robert Koch Institut (2025). Krebs in Deutschland f\u00fcr 2021\u20132023, Robert Koch Institut."},{"key":"ref_3","unstructured":"Robert Koch Institut (2023). Krebs in Deutschland f\u00fcr 2019\/2020, Robert Koch Institut."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jss.2019.12.041","article-title":"Pancreatic Fistula and Delayed Gastric Emptying Are the Highest-Impact Complications After Whipple","volume":"250","author":"Mirrielees","year":"2020","journal-title":"J. Surg. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jso.24125","article-title":"Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma","volume":"113","author":"Pugalenthi","year":"2016","journal-title":"J. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Enderes, J., Pillny, C., Matthaei, H., Manekeller, S., Kalff, J.C., and Glowka, T.R. (2023). Clinically Relevant Pancreatic Fistula after Pancreaticoduodenectomy: How We Do It. Biology, 12.","DOI":"10.3390\/biology12020178"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/SLA.0b013e3182813806","article-title":"Operative drainage following pancreatic resection: Analysis of 1122 patients resected over 5 years at a single institution","volume":"258","author":"MBrennan","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Dhayat, S.A., Tamim, A.N.J., Jacob, M., Ebeling, G., Kerschke, L., Kabar, I., and Senninger, N. (2021). Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0252727"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.hpb.2021.12.002","article-title":"A systematic review of post-pancreatectomy haemorrhage management stratified according to ISGPS grading","volume":"24","author":"Maccabe","year":"2022","journal-title":"HPB"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamasurg.2024.1228","article-title":"Hemorrhage Sites and Mitigation Strategies After Pancreaticoduodenectomy","volume":"159","author":"Preston","year":"2024","journal-title":"JAMA Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.hpb.2024.11.014","article-title":"Root-cause analysis of mortality after pancreatic resection in a nationwide cohort","volume":"27","author":"Henry","year":"2025","journal-title":"HPB"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s11605-019-04307-9","article-title":"In-hospital Mortality Following Pancreatoduodenectomy: A Comprehensive Analysis","volume":"24","author":"Merath","year":"2020","journal-title":"J. Gastrointest. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.hpb.2018.02.640","article-title":"Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: A nationwide audit","volume":"20","author":"Zwart","year":"2018","journal-title":"HPB"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.hpb.2018.04.008","article-title":"Ninety day mortality following pancreatoduodenectomy in England: Has the optimum centre volume been identified?","volume":"20","author":"Liu","year":"2018","journal-title":"HPB"},{"key":"ref_15","unstructured":"Statistisches Bundesamt (2025). Durchschnittliche Lebenserwartung (Periodensterbetafel): Deutschland, Jahre, Geschlecht, Vollendetes Alter, Statistisches Bundesamt."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bogaart, P. (2020). PantaRhei: Plots Sankey Diagrams, version 0.1.2, R-Project.","DOI":"10.32614\/CRAN.package.PantaRhei"},{"key":"ref_17","first-page":"806","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"335","author":"Altman","year":"2007","journal-title":"Lancet"},{"key":"ref_18","unstructured":"Zentrum f\u00fcr Krebsregisterdaten im Robert Koch-Institut (2026, March 15). Datenbankabfrage mit Sch\u00e4tzung der Inzidenz, Pr\u00e4valenz und des \u00dcberlebens von Krebs in Deutschland auf Basis der Epidemiologischen Landeskrebsregisterdaten. Mortalit\u00e4tsdaten Bereitgestellt vom Statistischen Bundesamt. Available online: www.krebsdaten.de\/abfrage."},{"key":"ref_19","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2024). S3-Leitlinie Exokrines Pankreaskarzinom Version 3.0, Leitlinienprogramm Onkologie."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Tempero","year":"2021","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hackner, D., Hobbs, M., Merkel, S., Siepmann, T., Krautz, C., Weber, G.F., Grutzmann, R., and Brunner, M. (2022). Impact of Patient Age on Postoperative Short-Term and Long-Term Outcome after Pancreatic Resection of Pancreatic Ductal Adenocarcinoma. Cancers, 14.","DOI":"10.3390\/cancers14163929"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e70647","DOI":"10.1002\/cam4.70647","article-title":"Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection from Retrospective Multi-Center Analysis (YPB-003)","volume":"14","author":"Matsui","year":"2025","journal-title":"Cancer Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.hpb.2022.12.007","article-title":"Is pancreatic head surgery safe in the elderly?","volume":"25","author":"Vigneron","year":"2023","journal-title":"HPB"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.yasu.2009.02.004","article-title":"What is the effect of age on pancreatic resection?","volume":"43","author":"Riall","year":"2009","journal-title":"Adv. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1634\/theoncologist.2017-0487","article-title":"Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis","volume":"23","author":"Shaib","year":"2018","journal-title":"Oncologist"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1245\/s10434-017-5994-0","article-title":"Impact of Patient Age on the Postoperative Survival in Pancreatic Head Cancer","volume":"24","author":"Sugiura","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.hpb.2022.01.011","article-title":"Prognostic models to predict survival in patients with pancreatic cancer: A systematic review","volume":"24","author":"Ioannou","year":"2022","journal-title":"HPB"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/SLA.0000000000006004","article-title":"Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Cohort Study","volume":"279","author":"Schouten","year":"2024","journal-title":"Ann. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Xu, Y., Zhang, Y., Han, S., Jin, D., Xu, X., Kuang, T., Wu, W., Wang, D., and Lou, W. (2022). Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.789351"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jhbp.320","article-title":"Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: A multicenter study","volume":"23","author":"Sho","year":"2016","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S2468-1253(23)00405-3","article-title":"Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): A multicentre, randomised, phase 2 trial","volume":"9","author":"Labori","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hpb.2019.06.019","article-title":"The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: A nationwide analysis","volume":"22","author":"Mackay","year":"2020","journal-title":"HPB"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12957-024-03393-7","article-title":"Adjuvant chemotherapy omission after pancreatic cancer resection: A French nationwide study","volume":"22","author":"Poiraud","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1007\/s11605-021-04949-8","article-title":"Mortality and Survival Among Octogenarians with Localized Pancreatic Head Cancer: A National Cancer Database Analysis","volume":"25","author":"Hue","year":"2021","journal-title":"J. Gastrointest. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaoncol.2021.5407","article-title":"Patterns of Adjuvant Chemotherapy Use and Association with Survival in Adults 80 Years and Older with Pancreatic Adenocarcinoma","volume":"8","author":"Mehtsun","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jamaoncol.2022.5808","article-title":"Association of Adjuvant Chemotherapy in Patients with Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy","volume":"9","author":"Sugawara","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"109544","DOI":"10.1016\/j.ejso.2024.109544","article-title":"Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette study","volume":"51","author":"Biesma","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamaoncol.2018.0329","article-title":"Total Neoadjuvant Therapy with FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"109693","DOI":"10.1016\/j.ejso.2025.109693","article-title":"An R0 resection margin does improve overall survival after PDAC resection\u2014Real-world evidence from 6.000 cases from the German Cancer Registry Group","volume":"51","author":"Duhn","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1200\/JCO.19.03318","article-title":"Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?","volume":"38","author":"Ferrone","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MPA.0000000000001231","article-title":"Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis","volume":"48","author":"Cloyd","year":"2019","journal-title":"Pancreas"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/SLA.0000000000000378","article-title":"Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer","volume":"260","author":"Merkow","year":"2014","journal-title":"Ann. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ejso.2016.07.016","article-title":"Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis","volume":"42","author":"Evans","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1200\/JCO.2016.68.5081","article-title":"Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis","volume":"35","author":"Mokdad","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/SLA.0000000000006730","article-title":"Neoadjuvant Chemotherapy with Gemcitabine and S-1 Versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II\/III Prep-02\/JSAP05 Trial","volume":"283","author":"Unno","year":"2026","journal-title":"Ann. Surg."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/15\/2423\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:09:55Z","timestamp":1785226195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/15\/2423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":47,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18152423"],"URL":"https:\/\/doi.org\/10.3390\/cancers18152423","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}